International Brain Research Foundation
Quercetin(International Brain Research Foundation)은 FRα 표적 세포·유전자 치료로, Recurrent Multiple Myeloma; Refractory Multiple Myeloma 영역에서 개발·상용화 중입니다. 작용기전: targets of QR and TBI, further highlighting the pivotal role of the Nrf2-Keap1 pathway. Phase 2에서 효능·안전성 신호를 검증 중입니다. ClinicalTrials.gov 기준 54건의 관련 임상이 등록되어 있습니다. 차별점: novel biomimetic nanostructure (MQCM) by anchoring mannose-modified quercetin nanodots (MQNDs) onto BV2 cell membrane fragmen.
FRα
Recurrent Multiple Myeloma; Refractory Multiple Myeloma
Recruiting
CAR T-cell therapy that promise to treat cancer without major sid
novel biomimetic nanostructure (MQCM) by anchoring mannose-modified quercetin nanodots (MQNDs) onto BV2 cell membrane fragmen
targets of QR and TBI, further highlighting the pivotal role of the Nrf2-Keap1 pathway
immune-mediated clearance by upregulating pro-survival and immune checkpoint pathways
DNA damage-related alterations, inflammatory responses, and stimulator of interferon genes (STING)-related signaling
biomarker stratification
resistance to precision oncology
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.
International Brain Research Foundation
Quercetin(International Brain Research Foundation)은 FRα 표적 세포·유전자 치료로, Recurrent Multiple Myeloma; Refractory Multiple Myeloma 영역에서 개발·상용화 중입니다. 작용기전: targets of QR and TBI, further highlighting the pivotal role of the Nrf2-Keap1 pathway. Phase 2에서 효능·안전성 신호를 검증 중입니다. ClinicalTrials.gov 기준 54건의 관련 임상이 등록되어 있습니다. 차별점: novel biomimetic nanostructure (MQCM) by anchoring mannose-modified quercetin nanodots (MQNDs) onto BV2 cell membrane fragmen.
FRα
Recurrent Multiple Myeloma; Refractory Multiple Myeloma
Recruiting
CAR T-cell therapy that promise to treat cancer without major sid
novel biomimetic nanostructure (MQCM) by anchoring mannose-modified quercetin nanodots (MQNDs) onto BV2 cell membrane fragmen
targets of QR and TBI, further highlighting the pivotal role of the Nrf2-Keap1 pathway
immune-mediated clearance by upregulating pro-survival and immune checkpoint pathways
DNA damage-related alterations, inflammatory responses, and stimulator of interferon genes (STING)-related signaling
biomarker stratification
resistance to precision oncology
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.